Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression.
<h4>Background & aims</h4>Progranulin (PGRN) is known to promote tumorigenesis and proliferation of several types of cancer cells. However, little is known about the clinicopathological features of patients with gastrointestinal stromal tumors (GISTs) with regard to PGRN expression.&...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0245153 |
id |
doaj-95cda3f5eb964cdea6518f4808c48dd0 |
---|---|
record_format |
Article |
spelling |
doaj-95cda3f5eb964cdea6518f4808c48dd02021-05-13T04:30:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024515310.1371/journal.pone.0245153Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression.In-Gu DoKyung Uk JungDong-Hoe KooYun-Gyoo LeeSukjoong OhKyungeun KimDong-Hoon KimJin Hee SohnByung Ho SonSung Ryol LeeJun Ho ShinHyung Ook KimHungdai KimHo-Kyung ChunGinette SerreroChang Hak Yoo<h4>Background & aims</h4>Progranulin (PGRN) is known to promote tumorigenesis and proliferation of several types of cancer cells. However, little is known about the clinicopathological features of patients with gastrointestinal stromal tumors (GISTs) with regard to PGRN expression.<h4>Methods</h4>A retrospective analysis was performed on patients with GISTs who underwent curative surgical resection between 2007 and 2017. PGRN expression was evaluated by immunohistochemical (IHC) analysis and semi-quantitatively categorized (no expression, 0; weak, 1+; moderate, 2+; strong, 3+). Tumors with a staining intensity of 2+ or 3+ were considered high PGRN expression.<h4>Results</h4>Fifty-four patients were analyzed; 31 patients (57%) were male. The median age at surgery was 60 years (range, 33-79), and the most common primary site was the stomach (67%). Thirty-five patients (65%) had spindle histology; 42 patients (78%) were separated as a high-risk group according to the modified National Institutes of Health (NIH) classification. High PGRN-expressing tumors were observed in 27 patients (50%), had more epithelioid/mixed histology (68% vs. 32%; p = 0.046), and KIT exon 11 mutations (76% vs. 24%; p = 0.037). Patients with high PGRN-expressing tumors had a worse recurrence-free survival (RFS) (36% of 5-year RFS) compared to those with low PGRN-expressing tumors (96%; p<0.001). Multivariate analysis showed that high PGRN expression and old age (>60 years) were independent prognostic factors for poor RFS.<h4>Conclusions</h4>High PGRN-expressing GISTs showed more epithelioid/mixed histology and KIT exon 11 mutations. PGRN overexpression was significantly associated with poor RFS in patients with GISTs who underwent curative resection.https://doi.org/10.1371/journal.pone.0245153 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
In-Gu Do Kyung Uk Jung Dong-Hoe Koo Yun-Gyoo Lee Sukjoong Oh Kyungeun Kim Dong-Hoon Kim Jin Hee Sohn Byung Ho Son Sung Ryol Lee Jun Ho Shin Hyung Ook Kim Hungdai Kim Ho-Kyung Chun Ginette Serrero Chang Hak Yoo |
spellingShingle |
In-Gu Do Kyung Uk Jung Dong-Hoe Koo Yun-Gyoo Lee Sukjoong Oh Kyungeun Kim Dong-Hoon Kim Jin Hee Sohn Byung Ho Son Sung Ryol Lee Jun Ho Shin Hyung Ook Kim Hungdai Kim Ho-Kyung Chun Ginette Serrero Chang Hak Yoo Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. PLoS ONE |
author_facet |
In-Gu Do Kyung Uk Jung Dong-Hoe Koo Yun-Gyoo Lee Sukjoong Oh Kyungeun Kim Dong-Hoon Kim Jin Hee Sohn Byung Ho Son Sung Ryol Lee Jun Ho Shin Hyung Ook Kim Hungdai Kim Ho-Kyung Chun Ginette Serrero Chang Hak Yoo |
author_sort |
In-Gu Do |
title |
Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
title_short |
Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
title_full |
Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
title_fullStr |
Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
title_full_unstemmed |
Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
title_sort |
clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2021-01-01 |
description |
<h4>Background & aims</h4>Progranulin (PGRN) is known to promote tumorigenesis and proliferation of several types of cancer cells. However, little is known about the clinicopathological features of patients with gastrointestinal stromal tumors (GISTs) with regard to PGRN expression.<h4>Methods</h4>A retrospective analysis was performed on patients with GISTs who underwent curative surgical resection between 2007 and 2017. PGRN expression was evaluated by immunohistochemical (IHC) analysis and semi-quantitatively categorized (no expression, 0; weak, 1+; moderate, 2+; strong, 3+). Tumors with a staining intensity of 2+ or 3+ were considered high PGRN expression.<h4>Results</h4>Fifty-four patients were analyzed; 31 patients (57%) were male. The median age at surgery was 60 years (range, 33-79), and the most common primary site was the stomach (67%). Thirty-five patients (65%) had spindle histology; 42 patients (78%) were separated as a high-risk group according to the modified National Institutes of Health (NIH) classification. High PGRN-expressing tumors were observed in 27 patients (50%), had more epithelioid/mixed histology (68% vs. 32%; p = 0.046), and KIT exon 11 mutations (76% vs. 24%; p = 0.037). Patients with high PGRN-expressing tumors had a worse recurrence-free survival (RFS) (36% of 5-year RFS) compared to those with low PGRN-expressing tumors (96%; p<0.001). Multivariate analysis showed that high PGRN expression and old age (>60 years) were independent prognostic factors for poor RFS.<h4>Conclusions</h4>High PGRN-expressing GISTs showed more epithelioid/mixed histology and KIT exon 11 mutations. PGRN overexpression was significantly associated with poor RFS in patients with GISTs who underwent curative resection. |
url |
https://doi.org/10.1371/journal.pone.0245153 |
work_keys_str_mv |
AT ingudo clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT kyungukjung clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT donghoekoo clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT yungyoolee clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT sukjoongoh clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT kyungeunkim clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT donghoonkim clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT jinheesohn clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT byunghoson clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT sungryollee clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT junhoshin clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT hyungookkim clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT hungdaikim clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT hokyungchun clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT ginetteserrero clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression AT changhakyoo clinicopathologicalcharacteristicsandoutcomesofgastrointestinalstromaltumorswithhighprogranulinexpression |
_version_ |
1721442793500442624 |